Literature DB >> 21997201

Calculated free testosterone and radioimmunoassay free testosterone as a predictor of subnormal levels of total testosterone.

Graziele Halmenschlager1, Ernani Luis Rhoden, Charles Edison Riedner.   

Abstract

PURPOSE: To evaluate the relationship among aFT, cFT, and total testosterone (TT) and the best method in diagnosing subnormal levels of TT.
METHODS: A total of 213 men were analyzed. Fasting blood samples were drawn for the determination of the lipid profile as well as of plasmatic glucose and serum levels of albumin, TT, aFT, and sex hormone-binding globulin (SHBG). The values of cFT were determined by Vermeulen's formula.
RESULTS: No correlation between aFT and cFT was observed (r = 0.062; P = 0.368), except after controlling for confounders (r = 0.188; P = 0.007). Only 44.8% of hypogonadal men (TT ≤ 300 ng/dL) were classified by aFT, whereas 72.4% of hypogonadal men were classified by both TT and cFT. Sensitivity, specificity, positive and negative predictive values, and positive likelihood ratio were greater in cFT when compared with aFT.
CONCLUSIONS: Our results suggest that cFT is more accurate in diagnosing subnormal levels of TT. Furthermore, we do not recommend using aFT due to its lack of accuracy. Further studies should be performed in order to evaluate the correlation between aFT and cFT with clinical signs and symptoms of androgen deficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997201     DOI: 10.1007/s11255-011-0066-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  29 in total

Review 1.  Evaluation of diagnostic procedures.

Authors:  J André Knottnerus; Chris van Weel; Jean W M Muris
Journal:  BMJ       Date:  2002-02-23

2.  An extraordinarily inaccurate assay for free testosterone is still with us.

Authors:  W Rosner
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

3.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

4.  Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms.

Authors:  Willem de Ronde; Yvonne T van der Schouw; Huibert A P Pols; Louis J G Gooren; Majon Muller; Diederick E Grobbee; Frank H de Jong
Journal:  Clin Chem       Date:  2006-06-22       Impact factor: 8.327

5.  Errors in the measurement of plasma free testosterone.

Authors:  W Rosner
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

Review 6.  The free hormone hypothesis: a physiologically based mathematical model.

Authors:  C M Mendel
Journal:  Endocr Rev       Date:  1989-08       Impact factor: 19.871

Review 7.  Serum bioavailability of sex steroid hormones.

Authors:  W M Pardridge
Journal:  Clin Endocrinol Metab       Date:  1986-05

8.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

9.  Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods.

Authors:  Karen K Miller; William Rosner; Hang Lee; Joan Hier; Gemma Sesmilo; David Schoenfeld; Gregory Neubauer; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

10.  The analog free testosterone assay: are the results in men clinically useful?

Authors:  S J Winters; D E Kelley; B Goodpaster
Journal:  Clin Chem       Date:  1998-10       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.